ClinicalTrials.gg
CompletedNCT04699708COSTAUpdated Nov 18, 2026

Co2 Monitoring at Preterm Delivery-Observational Study

An observational study in Resuscitation, sponsored by South Tees Hospitals NHS Foundation Trust. Completed at 2 sites in United Kingdom. Open to participants aged 23 Weeks to 32 Weeks. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by South Tees Hospitals NHS Foundation Trust · Observational

How we know

Updated Nov 18, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
23 Weeks to 32 Weeks
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 100 studies in Premature Birth with a site in United Kingdom — 19 open to participants now, 25 under way, 1 of them phase 3. Premature Birth · United Kingdom.

Enrollment
22nd of 46
150 · median 150
Started
2021
with 9 others
Observational
46 of 100
12 open now
Registered
67th of 100
by date
Lead sponsor
6 of 100
South Tees Hospitals NHS Foundation Trust

Among the 100 studies in Premature Birth with a site in United Kingdom, this one is the 22nd largest by enrollment of the 46 observational ones that give a count, is one of 10 that started in 2021, is one of 46 observational ones, and was the 67th registered.

Premature Birth

2,557 studies on the registry are indexed under Premature Birth; 504 are open to participants now.

Browse Premature Birth studies →

Open to participants now

19 of the 100 studies in Premature Birth with a site in United Kingdom are open now. Recruiting first, the newest first:

14 more — sign in →

All 19 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 318 Premature Birth studies recruiting now, 88 (28%) set no upper age limit and 226 (71%) stop at 75 or younger; 243 take children under 18; 104 take healthy volunteers.

This study: 23 Weeks to 32 Weeks · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 100 studies in Premature Birth with a site in United Kingdom, or all of them as a file.
02

Study summary

CO2 data, serving as a proxy marker for tidal volume, might enable titration of tidal volume/pressure thereby providing optimal ventilation during neonatal resuscitation.

Currently there is insufficient data on Co2 levels for preterm babies requiring resuscitation. This study involves monitoring of CO2 during preterm stabilisation.

Read the detailed description

Measurement of exhaled CO2 in the delivery room is feasible, but clinical benefits of during neonatal transition have not been studied. Volume ventilation in the Neonatal unit has been shown to improve outcomes such BPD or death. Despite the proven benefits of volume ventilation in the neonatal unit volume guided resuscitation at birth remains an unproven and under-studied technique.

CO2 data, serving as a proxy marker for tidal volume, might enable titration of tidal volume/pressure thereby providing optimal ventilation during neonatal resuscitation. Currently there is insufficient data on Co2 levels for preterm babies requiring resuscitation. This data would help in finding out optimal resuscitation strategies (Pressures/volume, frequency of breaths) rather than providing the same for all infants throughout the process of resuscitation and would help us in better interpretation Co2 levels in the future resuscitation.

Investigators aim to study the impact of various clinical (Gestation, Birth weight, need for intubation/bag-mask ventilation) and resuscitative factors (use of inflation pressures, ventilation pressures, frequency of breaths, face mask ventilation, intubation) on CO2 during preterm stabilisation.

03

Conditions studied

  • Resuscitation

Browse trials for

Keywords

  • Carbon dioxide monitoring
  • Preterm
  • Resuscitation
04

Who can participate

Ages eligible
23 Weeks to 32 Weeks
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All preterm infants ≤ 32 weeks born in two study centers receiving resuscitative measures at the time of birth either in the form of face mask ventilation or intubation.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. All preterm infants ≤ 32 weeks born at the study centres.
  2. Needing resuscitative measures at the time of birth either in the form of face mask ventilation or intubation.

Exclusion criteria

Exclusion Criteria:

  1. Preterm infants below the threshold of viability as determined by the study team.
  2. Major congenital or chromosomal abnormality (including congenital heart disease, Diaphragmatic hernia, congenital pulmonary airway malformations).
  3. Severe oligohydramnios (Amniotic fluid index \<5 or deep vertical pool≤2).
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (actual)
Patient registry
No

Groups and cohorts

  • Preterm infants ≤ 32 weeks

    All preterm infants ≤ 32 weeks born in two study centers receiving resuscitative measures at the time of birth either in the form of face mask ventilation or intubation.

    Device: Carbon dioxide monitoring

Interventions

  • DeviceCarbon dioxide monitoring

    Blinded recording of CO2 during preterm resuscitation.

06

What researchers measure

Primary outcomes

  1. Factors influencing carbon dioxide levels during preterm resuscitation

    To study the impact/correlation of various clinical factors (Gestation, Birth weight, need for intubation/bag-mask ventilation, surfactant administration, delayed cord clamping) and resuscitative factors (use of inflation pressures, ventilation pressures, frequency of breaths, face mask ventilation, intubation) on carbon dioxide measurements using MASIMO NOMOLINE capnography during preterm stabilisation.

    Time frame: 1 year

Secondary outcomes

  1. Correlation of Co2 with other parameters

    Correlation between oxygen saturation, CO2 and pulse rate.

    Time frame: 1 year

07

Study locations

2 sites
  • James Cook University Hospital
    Middlesbrough, STOCKTON ON TEES TS4 3BW, United Kingdom
  • Imran Ahmed
    Sunderland, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2021 to primary completion in Feb 2023, 20 months.

Of 373 non-industry observational studies under Premature Birth, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 63. This study's 20 months is below that.

Counting every sponsor, half of 388 studies reached it within 35 months; a quarter within 19 and three quarters within 61.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 18, 2026: primary completion Mar 2022 → Feb 2023 and completion Jun 2022 → Feb 2023.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Dec 30, 2020
First posted
Jan 7, 2021
StartActual
May 15, 2021
Primary completionActual
Feb 13, 2023was Mar 2022
CompletionActual
Feb 13, 2023was Jun 2022
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Completed
changed Nov 18, 2026
Sites
1 site added, 1 site removed
Show site
  • James Cook University Hospital · Middlesbrough, United Kingdom
Show 1 removed
  • James Cook University Hospital · Middlesbrough, United Kingdom
Nov 18, 2026
Primary completion
Mar 2022→Feb 13, 2023 (actual)
Nov 18, 2026
Study completion
Jun 2022→Feb 13, 2023 (actual)
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    Status unknown→Completed
    1 site added, 1 site removed
    Show site
    • James Cook University Hospital · Middlesbrough, United Kingdom
    Show 1 removed
    • James Cook University Hospital · Middlesbrough, United Kingdom
    Primary completion Mar 2022→Feb 13, 2023 (now actual)
    Study completion Jun 2022→Feb 13, 2023 (now actual)
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT04699708
Lead sponsor
South Tees Hospitals NHS Foundation Trust
Responsible party
Sponsor
First posted
Jan 7, 2021
Start date
May 15, 2021
Primary completion
Feb 13, 2023
Completion
Feb 13, 2023
Last update
Nov 18, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion